# The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury

> **NCT03007537** · NA · TERMINATED · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 101 (actual)

## Conditions studied

- Acute Kidney Injury
- Cardiac Disease
- Surgery

## Interventions

- **DRUG:** Erythropoietin
- **DRUG:** 0.9% sodium chloride
- **PROCEDURE:** cardiac surgery

## Key facts

- **NCT ID:** NCT03007537
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10-01
- **Primary completion:** 2018-12-28
- **Final completion:** 2018-12-28
- **Target enrollment:** 101 (ACTUAL)
- **Why stopped:** lack of funds
- **Last updated:** 2023-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007537, "The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT03007537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*